Category Archives: Pancreatic Cancer

A New Method to Treat Chemotherapy-Induced Neuropathic Pain

Posted on March 12, 2012 by wngai

If you are cancer patients and have to receive chemotherapy agents such as taxanes (paclitaxol- Taxol and docetaxel-Taxotere), vinca alkaloids (vinorelbine-Navelbine) and platinum compounds (cisplatin, carboplatin – Paraplatin and oxaliplatin – Eloxatin), it is likely that you might experience chemotherapy … Continue reading →

A New Agent That Might Change the Lives of Many Cancer Patients

Posted on October 16, 2011 by wngai

This is not only good news for all prostate cancer patients, but is also good news for all cancer patients. The investigational radiopharmaceutical radium-223 chloride (Alpharadin) has recently been shown to improve survival in patients with advanced prostate cancer and … Continue reading →

Posted in Anal Cancer, Bladder Cancer, Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gallbladder cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate cancer, Renal Cancer, Small Cell Lung Cancer, Thyroid Cancer | Tagged abiraterone, advanced prostate cancer, Alpharadin, ALSYMPCA, bone metastases, Cancer, carbitaxel, docetaxel, immunotherapy, Jevtana, Prostate cancer, Provenge, radium-223 chloride, sipuleucel-T, Stage IV cancers, Survival, Taxotere, Zytiga | Comments Off

FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

Posted on May 30, 2011 by wngai

The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs). pNETs is a rare, slow-growing form of pancreatic cancer. In theUnited States, there are fewer than 1000 new pNET cases … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged advanced renal cell carcinoma, Afinitor, Everolimus, FDA, mTOR, Nexavar, pancreatic neuroendocrine tumors, pNETs, RADIAN-3, sorafenib, subependymal giant cell astrocytoma, sunitinib, Sutent, tuberous sclerosis | Comments Off

Dietary Folate Intake Decreased Risk of Cancers

Posted on April 3, 2011 by wngai

Folate, also known as vitamin B9, is a water-soluble vitamin. The name of folate is derived from the Latin word folium, which means leaf. Folate is found naturally in green leafy vegetables, cereals, legumes and fruits, while folic acid is … Continue reading →

Posted in Alternative Medicine, Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Lung Cancer, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, Renal Cancer, Small Cell Lung Cancer, Vitamins | Tagged colorectal cancer, kidney cancer, oral cavity cancer, upper aerodigestive tract cancers, Uruguay | Comments Off

United States Was Ranked Seventh in Global Cancer Rates

Posted on April 2, 2011 by wngai

According to the data published by the American Institute for Cancer Research (AICR), the United States has the seventh highest cancer rate in the world, according to new data published by the American Institute for Cancer Research (AICR). Of the … Continue reading →

Posted in Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Gastric Cancer, Lung Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, Prostate cancer, Small Cell Lung Cancer | Tagged alcohol consumption, American Institute for Cancer Research, bladder cancer, Breast cancer, Cancer Rates, cervical cancer, colon cancer, Lung Cancer, Pancreatic Cancer, Prostate cancer, stomach cancer, tobacco consumption, uterine cancer | Comments Off

How to Prevent Common Cancers?

Posted on March 6, 2011 by wngai

The incidence and burden of cancer is huge. Nearly 12.7 million of people are diagnosed of cancer every day and 7.6 million die from cancer. The global cancer epidemic is set to continue rising, with the number of worldwide cancer … Continue reading →

Posted in Breast cancer, Cancer, Colorectal cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Pancreatic Cancer, Renal Cancer | Tagged American Institute for Cancer Research, body mass index, Breast cancer, Cancer, colon cancer, Endometrial cancer, Esophageal Cancer, hepatitis B, human papilloma virus, kidney cancer, Pancreatic Cancer, Prevent+, stomach cancer, World Cancer Congress, World Cancer Research Fund | 1 Comment

Europe Approved Sutent for Rare Pancreatic Cancer

Posted on December 22, 2010 by wngai

The European Commission has recently approved Sutent (sunitinib) as a medicine for treating patients with pancreatic neuroendocrine tumors (NET). The drug is now indicated to treat unresectable metastatic, well-differentiated pancreatic NET in adults with disease progression. The approval was based … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged metastatic, Pancreatic Cancer, pancreatic neuroendocrine tumors, progression-free survival, sunitinib, Sutent | Comments Off

Anorexia and Cachexia – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment

Posted on November 27, 2010 by wngai

Anorexia in Cancer Cancer anorexia-cachexia syndrome (CACS) is an extremely common condition in cancer patients. It is estimated that 50% of cancer patients suffered from anorexia. The exact frequency of CACS varies according to the primary pathology (from 30% in … Continue reading →

Posted in Cancer, Gastric Cancer, Others, Pancreatic Cancer | Tagged AIDS, Anorexia, Bristol-Myers Squibb, Cachexia, Causes, chemotherapy, cyprohetadine, Diagnosis, dronabinol, Gastric Cancer, Lymphoma, malnutrition, Marinol, Megace, megestrol, Merck, Metastatic breast cancer, orexigenic, Oxandrin, oxandrolone, Pancreatic Cancer, Periactin, Prognosis, Symptoms, Treatment, Unimed, wasting | 2 Comments

It is Better for Cancer Patients to Die at Home

Posted on November 14, 2010 by wngai

Cancer patients who die at home do so more peacefully and their caregivers also end up doing better emotionally, reported in the September 13th issue in the Journal of Clinical Oncology Wright’s team studied 342 terminal cancer patients and their … Continue reading →

Posted in Acute Promyelocytic Leukemia, Breast cancer, Cancer, Colorectal cancer, Esophageal Cancer, Gallbladder cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Non-Hodgkin's Disease, Ovarian Cancer, Pancreatic Cancer, Prostate cancer, Small Cell Lung Cancer | Tagged Cancer patients, Dying, emotion, Home, suffering, Survival | Comments Off

Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors

Posted on July 25, 2010 by wngai

Pancreatic neuroendocrine tumors affect the hormone-producing tissues within the pancreas, and have an incidence rate, affecting only 2 to 4 people per million worldwide. The incidence, however, is rising, and has quadrupled in the past 30 years, according to data … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged Affinitor, anthracyclines, Everolimus, fluoropyrimidines, Neuroendocrine tumor, octreotide, Pancreatic Cancer, Sandostatin, streptozocin, sunitinib, Survival, Sutent, Zanosar | Comments Off